BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mirzaei S, Hushmandi K, Zabolian A, Saleki H, Torabi SMR, Ranjbar A, SeyedSaleh S, Sharifzadeh SO, Khan H, Ashrafizadeh M, Zarrabi A, Ahn KS. Elucidating Role of Reactive Oxygen Species (ROS) in Cisplatin Chemotherapy: A Focus on Molecular Pathways and Possible Therapeutic Strategies. Molecules 2021;26:2382. [PMID: 33921908 DOI: 10.3390/molecules26082382] [Cited by in F6Publishing: 27] [Reference Citation Analysis]
Number Citing Articles
1 Ashrafizadeh M, Hushmandi K, Mirzaei S, Bokaie S, Bigham A, Makvandi P, Rabiee N, Thakur VK, Kumar AP, Sharifi E, Varma RS, Aref AR, Wojnilowicz M, Zarrabi A, Karimi‐maleh H, Voelcker NH, Mostafavi E, Orive G. Chitosan‐based nanoscale systems for doxorubicin delivery: Exploring biomedical application in cancer therapy. Bioengineering & Transla Med. [DOI: 10.1002/btm2.10325] [Reference Citation Analysis]
2 Li Q, Chen Z, Su L, Wu Y, Du W, Song J. Constructing turn-on bioluminescent probes for real-time imaging of reactive oxygen species during cisplatin chemotherapy. Biosens Bioelectron 2022;216:114632. [PMID: 35988429 DOI: 10.1016/j.bios.2022.114632] [Reference Citation Analysis]
3 Bin L, Yang Y, Wang F, Wang R, Fei H, Duan S, Huang L, Liao N, Zhao S, Ma X. Biodegradable Silk Fibroin Nanocarriers to Modulate Hypoxia Tumor Microenvironment Favoring Enhanced Chemotherapy. Front Bioeng Biotechnol 2022;10:960501. [DOI: 10.3389/fbioe.2022.960501] [Reference Citation Analysis]
4 Milan TM, Eskenazi APE, Bighetti-trevisan RL, de Almeida LO. Epigenetic modifications control loss of adhesion and aggressiveness of cancer stem cells derived from head and neck squamous cell carcinoma with intrinsic resistance to cisplatin. Archives of Oral Biology 2022. [DOI: 10.1016/j.archoralbio.2022.105468] [Reference Citation Analysis]
5 Ashrafizadeh M, Rabiee N, Prem Kumar A, Sethi G, Zarrabi A, Wang Y. Long noncoding RNAs (lncRNAs) in pancreatic cancer progression. Drug Discov Today 2022:S1359-6446(22)00202-1. [PMID: 35589014 DOI: 10.1016/j.drudis.2022.05.012] [Reference Citation Analysis]
6 Mirzaei S, Saghari S, Bassiri F, Raesi R, Zarrabi A, Hushmandi K, Sethi G, Tergaonkar V. NF-κB as a regulator of cancer metastasis and therapy response: A focus on epithelial-mesenchymal transition. J Cell Physiol 2022. [PMID: 35561232 DOI: 10.1002/jcp.30759] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
7 Fukuda T, Wada-hiraike O. The Two-Faced Role of Autophagy in Endometrial Cancer. Front Cell Dev Biol 2022;10:839416. [DOI: 10.3389/fcell.2022.839416] [Reference Citation Analysis]
8 Liu Z, Xu Y, Bai X, Guo L, Li X, Gao J, Teng Y, Yu P. Prediction of the mechanisms of action of Zhibai Dihaung Granule in cisplatin-induced acute kidney injury: A network pharmacology study and experimental validation. J Ethnopharmacol 2022;292:115241. [PMID: 35351575 DOI: 10.1016/j.jep.2022.115241] [Reference Citation Analysis]
9 Chandrashekar N, Subramanian R, Thiruvengadam D. Baicalein inhibits cell proliferation and enhances apoptosis in human A549 cells and benzo(a)pyrene-induced pulmonary carcinogenesis in mice. J Biochem Mol Toxicol 2022;:e23053. [PMID: 35332611 DOI: 10.1002/jbt.23053] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Shirmanova MV, Gavrina AI, Kovaleva TF, Dudenkova VV, Zelenova EE, Shcheslavskiy VI, Mozherov AM, Snopova LB, Lukyanov KA, Zagaynova EV. Insight into redox regulation of apoptosis in cancer cells with multiparametric live-cell microscopy. Sci Rep 2022;12:4476. [PMID: 35296739 DOI: 10.1038/s41598-022-08509-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Liu N, Zuo W, Wu L, Chen L, Xiao Z, Jin Q, Liu J, Tu L, Huo S, Zhu X. Myeloperoxidase-targeted nanotheranostics for self-enhanced synergetic photo/chemo/chemodynamic therapy. Materials Today Chemistry 2022;23:100740. [DOI: 10.1016/j.mtchem.2021.100740] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Paskeh MDA, Entezari M, Clark C, Zabolian A, Ranjbar E, Farahani MV, Saleki H, Sharifzadeh SO, Far FB, Ashrafizadeh M, Samarghandian S, Khan H, Ghavami S, Zarrabi A, Łos MJ. Targeted regulation of autophagy using nanoparticles: New insight into cancer therapy. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2022;1868:166326. [DOI: 10.1016/j.bbadis.2021.166326] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
13 Ngoepe MP, Clayton HS. Metal Complexes as DNA Synthesis and/or Repair Inhibitors: Anticancer and Antimicrobial Agents. Pharmaceutical Fronts 2021;03:e164-82. [DOI: 10.1055/s-0041-1741035] [Reference Citation Analysis]
14 El-Sheikh A, Khired Z. Interactions of Analgesics with Cisplatin: Modulation of Anticancer Efficacy and Potential Organ Toxicity. Medicina (Kaunas) 2021;58:46. [PMID: 35056355 DOI: 10.3390/medicina58010046] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Deldar Abad Paskeh M, Mirzaei S, Ashrafizadeh M, Zarrabi A, Sethi G. Wnt/β-Catenin Signaling as a Driver of Hepatocellular Carcinoma Progression: An Emphasis on Molecular Pathways. J Hepatocell Carcinoma 2021;8:1415-44. [PMID: 34858888 DOI: 10.2147/JHC.S336858] [Cited by in Crossref: 2] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
16 Gao L, Zhang X. Propofol enhances the lethality of cisplatin on liver cancer cells by up-regulating miR-195-5p. Tissue Cell 2021;74:101680. [PMID: 34808429 DOI: 10.1016/j.tice.2021.101680] [Reference Citation Analysis]
17 Fetoni AR, Paciello F, Troiani D. Cisplatin chemotherapy and cochlear damage: otoprotective and chemosensitization properties of polyphenols. Antioxid Redox Signal 2021. [PMID: 34731023 DOI: 10.1089/ars.2021.0183] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Abadi AJ, Mirzaei S, Mahabady MK, Hashemi F, Zabolian A, Hashemi F, Raee P, Aghamiri S, Ashrafizadeh M, Aref AR, Hamblin MR, Hushmandi K, Zarrabi A, Sethi G. Curcumin and its derivatives in cancer therapy: Potentiating antitumor activity of cisplatin and reducing side effects. Phytother Res 2021. [PMID: 34697839 DOI: 10.1002/ptr.7305] [Cited by in Crossref: 1] [Cited by in F6Publishing: 25] [Article Influence: 1.0] [Reference Citation Analysis]
19 Chen W, Zhao S, Yu W, Rao T, Ruan Y, Zhu S, Xia Y, Song H, Cheng F. SC66 inhibits the proliferation and induces apoptosis of human bladder cancer cells by targeting the AKT/β-catenin pathway. J Cell Mol Med 2021;25:10684-97. [PMID: 34687144 DOI: 10.1111/jcmm.17005] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
20 Zheng Y, Li X, Dong C, Ding L, Huang H, Zhang T, Chen Y, Wu R. Ultrasound‐Augmented Nanocatalytic Ferroptosis Reverses Chemotherapeutic Resistance and Induces Synergistic Tumor Nanotherapy. Adv Funct Materials 2022;32:2107529. [DOI: 10.1002/adfm.202107529] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
21 Mirzaei S, Saebfar H, Gholami MH, Hashemi F, Zarrabi A, Zabolian A, Entezari M, Hushmandi K, Samarghandian S, Aref AR, Ashrafizadeh M, Khan H. MicroRNAs regulating SOX2 in cancer progression and therapy response. Expert Rev Mol Med 2021;23:e13. [PMID: 34583803 DOI: 10.1017/erm.2021.15] [Cited by in Crossref: 1] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
22 Mapuskar KA, Steinbach EJ, Zaher A, Riley DP, Beardsley RA, Keene JL, Holmlund JT, Anderson CM, Zepeda-Orozco D, Buatti JM, Spitz DR, Allen BG. Mitochondrial Superoxide Dismutase in Cisplatin-Induced Kidney Injury. Antioxidants (Basel) 2021;10:1329. [PMID: 34572961 DOI: 10.3390/antiox10091329] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
23 Liang W, He X, Bi J, Hu T, Sun Y. Role of reactive oxygen species in tumors based on the 'seed and soil' theory: A complex interaction (Review). Oncol Rep 2021;46:208. [PMID: 34328200 DOI: 10.3892/or.2021.8159] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
24 Emanuele S, Celesia A, D'Anneo A, Lauricella M, Carlisi D, De Blasio A, Giuliano M. The Good and Bad of Nrf2: An Update in Cancer and New Perspectives in COVID-19. Int J Mol Sci 2021;22:7963. [PMID: 34360732 DOI: 10.3390/ijms22157963] [Cited by in F6Publishing: 11] [Reference Citation Analysis]
25 Mirzaei S, Gholami MH, Zabolian A, Saleki H, Farahani MV, Hamzehlou S, Far FB, Sharifzadeh SO, Samarghandian S, Khan H, Aref AR, Ashrafizadeh M, Zarrabi A, Sethi G. Caffeic acid and its derivatives as potential modulators of oncogenic molecular pathways: New hope in the fight against cancer. Pharmacol Res 2021;171:105759. [PMID: 34245864 DOI: 10.1016/j.phrs.2021.105759] [Cited by in F6Publishing: 24] [Reference Citation Analysis]
26 Mani S, Swargiary G, Tyagi S, Singh M, Jha NK, Singh KK. Nanotherapeutic approaches to target mitochondria in cancer. Life Sci 2021;281:119773. [PMID: 34192595 DOI: 10.1016/j.lfs.2021.119773] [Reference Citation Analysis]
27 Ashrafizadeh M, Mirzaei S, Hushmandi K, Rahmanian V, Zabolian A, Raei M, Farahani MV, Goharrizi MASB, Khan H, Zarrabi A, Samarghandian S. Therapeutic potential of AMPK signaling targeting in lung cancer: Advances, challenges and future prospects. Life Sci 2021;278:119649. [PMID: 34043989 DOI: 10.1016/j.lfs.2021.119649] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]